Working Group | Valuation

Objectives:

To initiate Request For Proposals (RFPs) that investigate new approaches to valuing health (including approaches within the scope of the QALY framework, as well as methods not necessarily associated with the conventional QALY paradigm).
To support the development and dissemination of EQ-5D-5L value sets in key countries. To stimulate interest in producing EQ-5D (3L and 5L) value sets in key countries across the world and assist the Executive in prioritising value sets for which support is requested.
To support methodological research examining the basis/rationale for value sets for patient groups.
To provide scientific guidance and support for existing protocols related to valuation studies.
To collaborate with other WGs or approved groups that work on conceptual and practical issues concerned with valuation of EQ-5D technologies.
To appraise the methodological reporting rigour of published value sets for approval by the Executive that the Business Office can post as guidance for users/user support.
To provide scientific guidance and support for valuation of bolt-on studies.

Co-Chair

Richard Norman

Members

Juan M. Ramos-Goñi

Rosalie Viney

Yaling Yang

Michal Jakubczyk

Marcel Jonker

Bram Roudijk

“EuroQol invests all income into EQ-5D research, education and user support.”

“EuroQol, the developer of the EQ-5D, is expert led.”

“EuroQol is a registered not-for-profit organization.”

“EuroQol is the single organization that manages the distribution and licensing of the EQ-5D family of instruments worldwide.”

“EuroQol consists of a large global network of experts, from a wide range of academic disciplines and countries/regions, who are committed to ongoing research on the EQ-5D family of instruments.”